Noteworthy, the blockade of Kv1.3 attenuated KA-induced epilepsy and inhibited microglial activation and the release of proinflammatory cytokines (such as IL-1β, IL-6, and TNF-α) through the Ca2+/NF-κB signaling pathway. Here, NFKB1 is linked to epilepsy.